CMO

52 Perspectives: “Future Outlook on the Biopharma Contract Manufacturing Landscape”

by Jae Chung

This week’s submission to ’52 Perspectives’ comes to us from Michael J.S. Thompson, Director of Business Development at Celltrion USA Inc., one of the world’s leading biologics contract manufacturing organizations for supply of clinical and commercial material 1.    What are the ranges of development and manufacturing services Celltrion, Inc. offers the pharma/biopharma industry? Headquartered in [...]

{ 0 comments }

52 Perspectives: “Strategies to reduce API manufacturing Costs”

by Jae Chung

This week’s submission of “52 Perspectives” comes to us from Britton Jimenez, the Vice President of Business Development at Penn Pharma, a leading provider of fully integrated and cost effective pharmaceutical development and custom manufacturing services to the international healthcare industry. 1.  What are the ranges of development and manufacturing services Penn Pharma offers the [...]

{ 2 comments }

52 Perspectives: “Key Success Factors in Contract Manufacturing Small-Molecule Drugs”

by Jae Chung

This week’s submission of 52 Perspectives comes to us from Derek Hennecke. Derek is the CEO and Presidenct of Xcelience LLC, a Florida based contract manufacturer offering Formulation, Analytical & Stability, and Manufacturing services for the pharmaceutical industry. Derek provides us with his thoughts on what steps contract manufacturers should take to stand apart from [...]

{ 0 comments }

“Expedia” for Pharma

by Jae Chung

The New York Times had a piece today on how the pharma industry has been relatively unscathed in Washington’s effort to overhaul the nation’s health care system.  Despite the $80 billion cost saving promise made by the drug industry to President Obama, some House leaders do not think the drug makers have given enough. While [...]

{ 0 comments }